Literature DB >> 2902263

Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.

P Aaby1, T G Jensen, H L Hansen, H Kristiansen, J Thårup, A Poulsen, M Sodemann, M Jakobsen, K Knudsen, M Clotilde da Silva.   

Abstract

In a randomised study of 558 children in an urban African community, the protective effect of the Edmonston-Zagreb (EZ) measles vaccine given in a dose of 40,000 plaque forming units from the age of 4 months was compared with the effects of a standard dose (6000 tissue culture infectious units) of Schwarz measles vaccine given from the age of 9 months. During two years of follow-up, all 14 clinical cases of measles occurred in the Schwarz group; 10 of the children contracted measles before vaccination and 4 after measles vaccination. Thus the EZ vaccine provided significant protection against measles both before and after the usual age of vaccination. Among the children who were exposed to measles at home, those given EZ vaccine were better protected than either unvaccinated children or those given the Schwarz vaccine.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Child; Child Mortality; Data Collection; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Evaluation; Guinea-bissau; Health; Health Services; Immunization; Infections; Measles--prevention and control; Mortality; Population; Population Characteristics; Population Dynamics; Portuguese Speaking Africa; Primary Health Care; Research Methodology; Vaccination; Viral Diseases; Western Africa; Youth

Mesh:

Substances:

Year:  1988        PMID: 2902263     DOI: 10.1016/s0140-6736(88)92780-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Measles epidemic in Harare, Zimbabwe, despite high measles immunization coverage rates.

Authors:  R A Kambarami; K J Nathoo; F K Nkrumah; D J Pirie
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

2.  Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.

Authors:  B Schlereth; J K Rose; L Buonocore; V ter Meulen; S Niewiesk
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Measles among under-9-month-olds in rural Bangladesh: its significance for age at immunization.

Authors:  V Fauveau; J Chakraborty; A M Sarder; M A Khan; M A Koenig
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

4.  Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.

Authors:  P Aaby; I M Lisse; H Whittle; K Knudsen; J Thaarup; A Poulsen; M Sodemann; M Jakobsen; L Brink; U Gansted
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

5.  Measles prevention and control in emergency settings.

Authors:  M J Toole; R W Steketee; R J Waldman; P Nieburg
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

6.  A role for INDEPTH Asian sites in translating research to action for non-communicable disease prevention and control: a case study from Ballabgarh, India.

Authors:  Anand Krishnan; Baridalyne Nongkynrih; Suresh Kumar Kapoor; Chandrakant Pandav
Journal:  Glob Health Action       Date:  2009-09-28       Impact factor: 2.640

7.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

8.  Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.

Authors:  P Aaby; M Andersen; M Sodemann; M Jakobsen; J Gomes; M Fernandes
Journal:  BMJ       Date:  1993-11-20

9.  Evidence that measles virus hemagglutinin initiates modulation of leukocyte function-associated antigen 1 expression.

Authors:  A R Nagendra; C W Smith; P R Wyde
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.

Authors:  P Kiepiela; H M Coovadia; W E Loening; P Coward; G Botha; J Hugo; P J Becker
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.